CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Fisher & Paykel Healthcare - FPHau CFD

23.514
2.72%
Market Trading Hours* (UTC) Opens on Tuesday at 00:00

Mon: 23:02 - 00:00

Tue - Wed: 00:00 - 05:00 23:02 - 00:00

Thu: 00:00 - 05:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.122
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.022726 %
Charges from full value of position ($-4.32)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.022726%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.000808 %
Charges from full value of position ($0.15)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.000808%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency AUD
Margin 5%
Stock exchange Australia
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 24.172
Open* 23.653
1-Year Change* -3.07%
Day's Range* 23.234 - 24.242
52 wk Range 18.02-34.55
Average Volume (10 days) 420.64K
Average Volume (3 months) 11.40M
Market Cap 12.01B
P/E Ratio 32.16
Shares Outstanding 577.13M
Revenue 1.68B
EPS 0.65
Dividend (Yield %) 1.88995
Beta 0.74
Next Earnings Date Nov 28, 2022

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 28, 2024 23.514 -0.399 -1.67% 23.913 24.262 23.134
Mar 27, 2024 23.913 -0.439 -1.80% 24.352 24.362 23.504
Mar 26, 2024 24.342 0.299 1.24% 24.043 24.412 23.933
Mar 25, 2024 24.033 -0.469 -1.91% 24.502 24.701 23.833
Mar 24, 2024 24.502 0.849 3.59% 23.653 24.502 23.653
Mar 22, 2024 24.113 0.380 1.60% 23.733 24.172 23.454
Mar 21, 2024 23.743 1.467 6.59% 22.276 24.013 22.176
Mar 20, 2024 22.286 0.389 1.78% 21.897 22.316 21.857
Mar 19, 2024 21.887 -0.219 -0.99% 22.106 22.206 21.837
Mar 18, 2024 22.106 0.149 0.68% 21.957 22.326 21.887
Mar 17, 2024 21.957 0.000 0.00% 21.957 21.997 21.847
Mar 15, 2024 22.086 -0.230 -1.03% 22.316 22.316 22.007
Mar 14, 2024 22.306 -0.309 -1.37% 22.615 22.695 22.296
Mar 13, 2024 22.625 -0.230 -1.01% 22.855 23.025 22.585
Mar 12, 2024 22.845 0.260 1.15% 22.585 22.845 22.486
Mar 11, 2024 22.585 -0.250 -1.09% 22.835 22.855 22.476
Mar 10, 2024 22.835 -0.020 -0.09% 22.855 22.905 22.735
Mar 8, 2024 23.164 0.359 1.57% 22.805 23.254 22.605
Mar 7, 2024 22.805 -0.280 -1.21% 23.085 23.114 22.695
Mar 6, 2024 23.085 0.290 1.27% 22.795 23.204 22.665

Fisher & Paykel Healthcare Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total revenue 1581.1 1681.7 1971.2 1263.7 1070.4
Revenue 1581.1 1681.7 1971.2 1263.7 1070.4
Cost of Revenue, Total 642.7 629 725.6 427.9 354.6
Gross Profit 938.4 1052.7 1245.6 835.8 715.8
Total Operating Expense 1248.9 1176.1 1258.9 884.4 777.8
Selling/General/Admin. Expenses, Total 431.9 393.1 396.6 338 327.8
Research & Development 174.3 154 136.7 118.5 100.4
Other Operating Expenses, Total 0 -5
Operating Income 332.2 505.6 712.3 379.3 292.6
Interest Income (Expense), Net Non-Operating -4.2 -1.4 5.9 -8.8 -1.4
Net Income Before Taxes 328 504.2 718.2 370.5 291.2
Net Income After Taxes 250.3 376.9 524.2 287.3 209.2
Net Income Before Extra. Items 250.3 376.9 524.2 287.3 209.2
Net Income 250.3 376.9 524.2 287.3 209.2
Income Available to Common Excl. Extra. Items 250.3 376.9 524.2 287.3 209.2
Income Available to Common Incl. Extra. Items 250.3 376.9 524.2 287.3 209.2
Diluted Net Income 250.3 376.9 524.2 287.3 209.2
Diluted Weighted Average Shares 581.631 579.993 579.588 579.05 578.051
Diluted EPS Excluding Extraordinary Items 0.43034 0.64984 0.90444 0.49616 0.36191
Dividends per Share - Common Stock Primary Issue 0.405 0.395 0.38 0.275 0.2325
Diluted Normalized EPS 0.43034 0.64984 0.90444 0.49616 0.39099
Dilution Adjustment
Mar 2023 Sep 2022 Mar 2022 Sep 2021 Mar 2021
Total revenue 890.5 690.6 781.7 900 1061
Revenue 890.5 690.6 781.7 900 1061
Cost of Revenue, Total 365.3 277.4 296.7 332.3 377.3
Gross Profit 525.2 413.2 485 567.7 683.7
Total Operating Expense 685 563.9 578.5 597.6 657.9
Selling/General/Admin. Expenses, Total 229.6 202.3 203.5 189.6 208.5
Research & Development 90.1 84.2 78.3 75.7 72.1
Operating Income 205.5 126.7 203.2 302.4 403.1
Interest Income (Expense), Net Non-Operating 8.2 -12.4 -0.1 -1.3 2.1
Net Income Before Taxes 213.7 114.3 203.1 301.1 405.2
Net Income After Taxes 154.4 95.9 155.1 221.8 298.7
Net Income Before Extra. Items 154.4 95.9 155.1 221.8 298.7
Net Income 154.4 95.9 155.1 221.8 298.7
Income Available to Common Excl. Extra. Items 154.4 95.9 155.1 221.8 298.7
Income Available to Common Incl. Extra. Items 154.4 95.9 155.1 221.8 298.7
Diluted Net Income 154.4 95.9 155.1 221.8 298.7
Diluted Weighted Average Shares 582.757 580.505 580.213 579.772 579.727
Diluted EPS Excluding Extraordinary Items 0.26495 0.1652 0.26732 0.38256 0.51524
Dividends per Share - Common Stock Primary Issue 0.23 0.175 0.225 0.17 0.22
Diluted Normalized EPS 0.26495 0.1652 0.26732 0.38256 0.51524
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total Current Assets 774.2 887.9 920 518.7 455.3
Cash and Short Term Investments 121 289.9 377.6 144.8 140.7
Cash & Equivalents 121 89.9 97.3 67.1 48.2
Total Receivables, Net 254.2 182.7 228.9 223.3 159.3
Accounts Receivable - Trade, Net 179.6 142.8 191.7 192.9 136
Total Inventory 365.8 358.9 270.6 146.5 136.1
Other Current Assets, Total 33.2 56.4 42.9 4.1 19.2
Total Assets 2204.5 2107 2075 1435 1206.7
Property/Plant/Equipment, Total - Net 1148.2 957.8 882.1 735.3 601.4
Property/Plant/Equipment, Total - Gross 1632.6 1390.8 1262.9 1054.8 874.5
Accumulated Depreciation, Total -484.4 -433 -380.8 -319.5 -273.1
Intangibles, Net 85.6 86.8 80 73.9 61.5
Note Receivable - Long Term 29.9 3.2 7.6 2.3 2.6
Other Long Term Assets, Total 166.6 171.3 185.3 104.8 85.9
Total Current Liabilities 289.8 303.9 427.5 334.6 184.4
Accounts Payable 43 53.8 56.7 69.3 55.1
Accrued Expenses 94.5 93.8 87.5 57.1 47.4
Notes Payable/Short Term Debt 4.2 5.3 11.9 30.7 17.3
Current Port. of LT Debt/Capital Leases 17.1 11.7 14.7 61.5 0
Other Current Liabilities, Total 131 139.3 256.7 116 64.6
Total Liabilities 451.1 427.3 554.1 461.2 293.5
Total Long Term Debt 124.5 87.3 91.8 44 69
Long Term Debt 79.1 63 62.8 22 69
Deferred Income Tax 3.1 0 23.3
Other Liabilities, Total 33.7 36.1 34.8 82.6 16.8
Total Equity 1753.4 1679.7 1520.9 973.8 913.2
Common Stock 307 266.3 251.3 229 221
Retained Earnings (Accumulated Deficit) 1222.9 1198.5 1049.5 714 562.1
Treasury Stock - Common -3.3 -5.1 -2.2 -3.6 -1.8
Unrealized Gain (Loss) 169.7 122.1 122.1 87.6 87.6
Other Equity, Total 57.1 97.9 100.2 -53.2 44.3
Total Liabilities & Shareholders’ Equity 2204.5 2107 2075 1435 1206.7
Total Common Shares Outstanding 579.219 577.13 576.275 574.281 573.498
Short Term Investments 0 200 280.3 77.7 92.5
Capital Lease Obligations 45.4 24.3 29 22
Mar 2023 Sep 2022 Mar 2022 Sep 2021 Mar 2021
Total Current Assets 774.2 723.8 887.9 867.7 920
Cash and Short Term Investments 121 69.8 289.9 288.4 377.6
Cash & Equivalents 121 69.8 89.9 103.2 97.3
Short Term Investments 0 0 200 185.2 280.3
Total Receivables, Net 254.2 222.6 182.7 248.6 228.9
Accounts Receivable - Trade, Net 218.5 198.2 174.4 236.6 222.5
Total Inventory 365.8 398.4 358.9 291.8 270.6
Other Current Assets, Total 33.2 33 56.4 38.9 42.9
Total Assets 2204.5 2094.5 2107 2045.4 2075
Property/Plant/Equipment, Total - Net 1148.2 1044.8 957.8 917.3 882.1
Intangibles, Net 85.6 88.3 86.8 83.5 80
Note Receivable - Long Term 29.9 29.5 3.2 1.8 7.6
Other Long Term Assets, Total 166.6 208.1 171.3 175.1 185.3
Total Current Liabilities 289.8 368.6 303.9 314.3 427.5
Payable/Accrued 219.7 204.6 226.2 224.6 233.3
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 21.3 57.3 17 23.5 26.6
Other Current Liabilities, Total 48.8 106.7 60.7 66.2 167.6
Total Liabilities 451.1 616.1 427.3 454.6 554.1
Total Long Term Debt 124.5 110.4 87.3 91 91.8
Long Term Debt 79.1 70 63 63.5 62.8
Capital Lease Obligations 45.4 40.4 24.3 27.5 29
Other Liabilities, Total 33.7 137.1 36.1 49.3 34.8
Total Equity 1753.4 1478.4 1679.7 1590.8 1520.9
Common Stock 307 264.9 266.3 255.5 251.3
Retained Earnings (Accumulated Deficit) 1449.7 1213.5 1418.5 1335.3 1271.8
Total Liabilities & Shareholders’ Equity 2204.5 2094.5 2107 2045.4 2075
Total Common Shares Outstanding 579.219 577.491 577.13 577.131 576.275
Treasury Stock - Common -3.3 -5.1 -2.2
Deferred Income Tax 3.1
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Cash From Operating Activities 238.2 324.3 625.3 321.4 253.3
Cash Receipts 1543 1732.4 1965.3 1200.9 1058.1
Cash Payments -1177.4 -1155.7 -1205.1 -785.2 -726.9
Cash Taxes Paid -121.2 -249.7 -131.5 -93.2 -81.6
Cash Interest Paid -9 -4.8 -4.9 -5.2 -4.6
Changes in Working Capital 2.8 2.1 1.5 4.1 8.3
Cash From Investing Activities -11.3 -89.5 -387.3 -155.7 -125.7
Capital Expenditures -211.3 -169.8 -184.7 -170.7 -133.3
Other Investing Cash Flow Items, Total 200 80.3 -202.6 15 7.6
Cash From Financing Activities -197.1 -235.8 -188 -159 -113.1
Financing Cash Flow Items 3 3.2 3.5 2.3 1.8
Total Cash Dividends Paid -195.7 -224.9 -181.3 -146.4 -114.6
Issuance (Retirement) of Stock, Net 0.3
Issuance (Retirement) of Debt, Net -4.4 -14.1 -10.2 -14.9 -0.6
Foreign Exchange Effects 2.4 0.2 -1 -1.2 0.6
Net Change in Cash 32.2 -0.8 49 5.5 15.1
Mar 2023 Sep 2022 Mar 2022 Sep 2021 Mar 2021
Cash From Operating Activities 238.2 1.9 324.3 127.5 625.3
Cash Receipts 1543 675.4 1732.4 883.1 1965.3
Cash Payments -1177.4 -595.4 -1155.7 -565.9 -1205.1
Cash Taxes Paid -121.2 -76.1 -249.7 -188 -131.5
Cash Interest Paid -9 -4 -4.8 -2.7 -4.9
Changes in Working Capital 2.8 2 2.1 1 1.5
Cash From Investing Activities -11.3 75.2 -89.5 13.8 -387.3
Capital Expenditures -211.3 -124.8 -169.8 -81.3 -184.7
Other Investing Cash Flow Items, Total 200 200 80.3 95.1 -202.6
Cash From Financing Activities -197.1 -107.5 -235.8 -131.9 -188
Financing Cash Flow Items 3 1.6 3.2 1.5 3.5
Total Cash Dividends Paid -195.7 -129.9 -224.9 -126.8 -181.3
Issuance (Retirement) of Debt, Net -4.4 20.8 -14.1 -6.6 -10.2
Foreign Exchange Effects 2.4 6.6 0.2 -0.4 -1
Net Change in Cash 32.2 -23.8 -0.8 9 49

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Fisher & Paykel Healthcare Company profile

Fisher & Paykel Healthcare Corporation Limited
Industry: Medical Equipment, Supplies & Distribution (NEC)

15 Maurice Paykel Place
East Tamaki,
AUCKLAND
2013
NZ

Income Statement

  • Annual
  • Quarterly

News

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

People also watch

Gold

2,233.43 Price
+1.740% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 21:00 (UTC)
Spread 0.80

XRP/USD

0.63 Price
-1.420% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

ETH/USD

3,543.77 Price
-0.570% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

BTC/USD

69,988.60 Price
-1.120% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading